At the 44th Annual J.P. Morgan Healthcare Conference, McKesson’s CEO Brian Tyler opened by acknowledging the company’s 40,000 employees and underscoring McKesson’s commitment to transparency, advising attendees to refer to the forward-looking statements and non-GAAP disclosures available on the company’s website. Tyler emphasized McKesson’s leadership role in healthcare distribution and set the stage for a deeper dive into the company’s strategic initiatives.

McKesson distributes approximately 33% of all pharmaceuticals across North America each day, serving a wide range of constituents including pharmacies, providers, biopharma manufacturers, payers and patients. The company leverages scaled and scalable platforms—spanning wholesale distribution, specialty services and technology solutions—to meet the evolving needs of the healthcare ecosystem.

The company’s technology-enabled network integrates with over 1,000,000 healthcare providers and 50,000 pharmacies, embedding McKesson’s workflows into point-of-care operations. This connectivity not only drives operational efficiencies but also positions McKesson as a critical partner for digital health adoption and data-driven care management.

Through its US Oncology Network management services organization (USON MSO), McKesson will touch more than 20% of all cancer patients in the United States this year. This scale in oncology care coordination underscores McKesson’s expanding role in specialty distribution and value-based care models, as the company continues to invest in clinical support and network expansion.